Novel naphthalimide polyamine derivatives as potential antitumor agents

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Biochemistry

Background:

• Naphthalimide derivatives are explored for their anticancer properties.
• Developing novel antiproliferative agents is crucial for cancer therapy.

Purpose of the Study:

• To design, synthesize, and evaluate novel naphthalimide polyamine conjugates for antiproliferative activity.
• To investigate the mechanism of action, including DNA binding and cell cycle effects.

Main Methods:

• Synthesis of naphthalimide polyamine conjugates.
• In vitro antiproliferative assays against human cancer cell lines (Jurkat, HeLa, MCF-7, A549).
• Cell cycle analysis, DNA binding studies (ethidium bromide displacement assay), topoisomerase activity assays, and fluorescence microscopy.

Main Results:

• Compounds I1 and A3 exhibited the highest antiproliferative activity (IC50 values: 5.67-11.02 μmol·L⁻¹).
• Compound I1 induced S and G2/M phase arrest, followed by apoptosis (sub-G0/G1).
• Compound A3 induced G0/G1 and G2/M phase arrest, followed by apoptosis, and showed non-intercalating DNA binding (Kapp = 3.1 × 10⁶ M⁻¹).
• No inhibition of topoisomerase I or II activity was observed.
• Naphthalimide polyamine conjugates rapidly penetrated cancer cells.

Conclusions:

• Naphthalimide polyamine conjugates, particularly I1 and A3, show promising in vitro antiproliferative activity against diverse cancer cell lines.
• Compound A3's non-intercalating DNA binding suggests a unique mechanism of action.
• These compounds rapidly enter cancer cells, warranting further investigation into their precise mechanisms and structure-activity relationships for potential therapeutic development.